Portage Biotech Inc.

NasdaqCM:PRTG Stock Report

Market Cap: US$5.8m

Portage Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PRTG Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Sep 24SellUS$1,235,560Gregory BaileyIndividual70,000US$18.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PRTG?
Owner TypeNumber of SharesOwnership Percentage
Private Companies35,6603.18%
Institutions192,81817.2%
Individual Insiders273,71724.4%
General Public618,86455.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.4%.

Top Shareholders

Top 25 shareholders own 44.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
James Mellon
146,585US$753.4k0%no data
9.01%
Gregory Bailey
101,016US$519.2k-40.6%no data
8.79%
Bison Wealth, LLC
98,521US$506.4k823%0.08%
4.91%
Armistice Capital LLC
55,081US$283.1k-26.7%0.01%
3.18%
SalvaRx Group plc
35,660US$183.3k0%no data
1.35%
Ian Walters
15,130US$77.8k0%no data
0.97%
Virtu Financial LLC, Asset Management Arm
10,919US$56.1k0%no data
0.9%
Renaissance Technologies LLC
10,058US$51.7k165%no data
0.71%
Connective Capital Management, LLC
7,909US$40.7k0%0.04%
0.63%
Robert Kramer
7,037US$36.2k0%no data
0.45%
Galloway Ltd.
5,039US$25.9k0%0.34%
0.25%
Steven Mintz
2,766US$14.2k0%no data
0.22%
UBS Asset Management AG
2,466US$12.7k440%no data
0.17%
Seed Innovations Limited
1,907US$9.8k0%1.67%
0.11%
Robert Glassman
1,182US$6.1k0%no data
0.036%
BlackRock, Inc.
408US$2.1k-0.49%no data
0.011%
Morgan Stanley, Investment Banking and Brokerage Investments
125US$642.50.81%no data
0.0095%
Geode Capital Management, LLC
107US$549.7-76.5%no data
0.0067%
RBC Dominion Securities Inc., Asset Management Arm
75US$385.50%no data
0.0065%
National Bank Investments Inc.
73US$375.11.39%no data
0.0061%
Amundi Asset Management SAS
68US$349.81.49%no data
0.0031%
Wells Fargo & Company, Securities and Brokerage Investments
35US$179.80%no data
0.00098%
Carson Wealth Management Group
11US$56.510%no data
0.00071%
Princeton Global Asset Management LLC
8US$40.914.3%no data
0.00062%
BNP Paribas Arbitrage Sa, Asset Management Arm
7US$35.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 23:43
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Portage Biotech Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin WalshB. Riley Securities, Inc.
Li Wang WatsekCantor Fitzgerald & Co.
Kevin DeGeeterOppenheimer & Co. Inc.